Clinicopathologic Analysis of Malignant Melanoma |
Lee, Dong Hoon
(Department of Dermatology, Yonsei University College of Medicine)
Kim, You Chan (Department of Dermatology, Dankook University, College of Medicine) Cho, Sang-Ho (Department of Pathology, Yonsei University College of Medicine) Lee, Min-Geol (Department of Dermatology, Yonsei University College of Medicine) |
1 | McGovern VJ, Mihm MC Jr, Bailly C, Booth JC, Clark WH Jr, Cochran AJ, et al. The classification of malignant melanoma and its histologic reporting. Cancer 1973; 32:1446-1455 DOI ScienceOn |
2 | Koh HK, Bhawan J. Tumors of the skin. In: Moschella SL. Hurley HJ, eds. Dermatology. 3rd ed. Philadelphia: W. B Saunders, 1992;1721-1808 |
3 | Kheir SM, Bines SD, Vonroenn JH. Prognostic significance of DNA aneuploidy in stage I cutaneous melanoma. Ann Surg· 1988;207:455-461 DOI PUBMED ScienceOn |
4 | Huvos AG, Shah JP, Mike V. Prognostic factors in cutaneous malignant melanoma. Hum Pathol 1974;5:347-357 DOI ScienceOn |
5 | Koh UK, Michalik E, Sober AJ. Lentigo maligna melanoma has no better prognosis than other type of melanoma. J Clin Oncol 1984;2:994-1001 DOI PUBMED |
6 | Calvin AR, Tina JH, Salve GR. Acral lentiginous melanoma. Arch Surg 1995;130:88-92 DOI PUBMED ScienceOn |
7 | Weissmann A, Rosis DF, Harris MN. Prediction of lymph node metastases from the histologic feature of primary cutaneous malignant melanoma. Am J Dermatopathol 1984;6:35s DOI ScienceOn |
8 | Lin CS, Wang WJ, Wong CK. Acral melanoma: a clinicopathologic study of 28 patients. Int J Dermatol 1990;29:107-12 DOI PUBMED |
9 | Morton DL, Dabtyan DG, Wanek LA, Foshang LJ, Cochran AJ. Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thickness. Cancer 1993;71:3737-43 DOI ScienceOn |
10 | 조광현, 조이경, 이유신, 함의근. 선단흑색종의 임상 및 병리조직학적 고찰. 대피지 1989;27:388-394 |
11 | Balch CM, Soong SJ, Shaw HM, Urist MM, McCarthy WH. An analysis of prognostic factors in 8500 patients with cutaneous melanoma. In: Balch CM, editor. Cutaneous melanoma. 2nd ed. Philadelphia:JB Lippincott, 1992;165-87 |
12 | 원영호, 허수경, 이승철, 전인기, 김영표. 최근 10년간 악성 흑색종의 임상 및 병리조직학적 연구. 대피지 1991;29:193-202 |
13 | 장경애, 김종혁, 최지호, 성경제, 문기찬, 고재경. 악성 흑색종의 임상 및 병리조직학적 고찰. 대피지 2000;38:1435-1443 |
14 | Balch CM, Houghton AN. Diagnosis of metastatic melanoma at distant sites. In: Balch CM, CM, Houghton AN, Milton GW, Sober AJ, Soong S, eds. Cutaneous melannoma, 2nd ed. Philadelphia;JB Lippincott, 1992;439-467 |
15 | Balch CM, Milton GW, Shaw HM. Cutaneous Melanoma: Clinical management and treatment results worldwide. Philadelphia, JB Lippincott, 1985;13-506 |
16 | 김수남, 전수일, 순숙자, 조백기, 김종민, 김낙인등. 한국인의 악성 흑색종에 관한 관찰. 대한피부과학회 제38차 추계학술대회 초록집 1986;29-30 |
17 | 김우호, 박성희, 이현순. 점막에 발생한 악성 혹색종 27예의 병리학적 관찰. 대한암학회지 1986;18:177-182 |
18 | Irwin M. Freedberg, Arthur Z. Eisen, Klaus Wolff, K. Frank Austen, Lowell A. Goldsmith, Stephen I. Katz, Thomas B. Fitzpatric k. Fitzpatrick's dermatology in general medicine. 5th ed. New York: McGraw-Hill, 1030-1116 |
19 | Kopf AW, Gross DF, Rogers GS. Prognostic index for malignant melanoma. Cancer 1987;59:1238-1241 |
20 | Krementz ET, Feed RJ, Coleman WP III, Sutherland CM, Carter RD, Campbell M. Acral lentiginous melanoma: a clinical pathological entity. Ann Surg 1982;195:632-45 DOI PUBMED ScienceOn |
21 | Collins RJ: Melanoma in the Chinese of· Hongkong, Emphasis on volar and subungal sites. Cancer 1984;54;1482-1488 DOI PUBMED ScienceOn |
22 | 송계용, 정경천, 조광현, 지제근, 함의근. 악성 흑색종의 입상 및 병리조직학적 고찰:104 증례 검색. 대한병리학회지 1997;31:566-573 |
23 | Yoshie K, Kazuyuki I, Naoya Y, Kiyoshi H. Clinical and pathologic features of cutaneous malignant melanom a : a retrospective analysis of 124 Japanese patients. Jpn J Clin Oncol 1996;26:144-51 DOI PUBMED ScienceOn |
24 | Silver HK, Karim KA, Le-Riche-J. Nuclear DNA, serum sialic acid and measured depth in malignant melanoma for predicting disease recurrence and survival. Int J Cancer 1989;44:31-34 DOI PUBMED |
25 | Lever WF. Schamburg-Lever G. Histopathology of the Skin. Philadelphia, JB Lippincott, 1990;780-805 |
26 | Sober AJ, Day CI. Jr, Fitzpatrick TB. Factors associated with death from melanoma from 2 to 5 years following diagnosis in clinical stage I patients. J Invest Dermatol 1983;80:53s-55s DOI PUBMED |
27 | Shaw HM, McGovern VJ, Milton GW. Malignant melanoma : influence of site lesion and age of patient in the female superiority in survival. Cancer 1980;46:2731-2735 DOI ScienceOn |
28 | Schuchtlilr L , SchultzDJ, Synnestvedt M, Trock BJ, Guerry D, Elder DE, et al. The Pigmented Lesion Group. A prognostic model for predicting lO-year survival with primary melanoma. Ann Intern Med 1996;125:369-75 DOI PUBMED ScienceOn |
29 | Elder D. Elenitsas R, Jaworsky C, Johnson B. Lever's histopathology of the skin. 8th eds. Philadelphia:Lippincott-Raven, 1997:625-684 |
30 | Yi-Ju Chen, Chun-Ying Wu, Jung-Ta Chen, Jui-Lung Shen, Chien-Chou Chen, Hsi-Ching Wang. Clinicopathologic analysis of malignant melanoma in Taiwan. J Am Acad Dermatol 1999;41 :945-9 DOI ScienceOn |
31 | Landis SH, Murray T. Bolden S, Wingo PA. Cancer statistics, 1998. CA Cancer J Clin 1998;48:6-29 DOI ScienceOn |